e-learning
resources
Glasgow 2004
Sunday 05.09.2004
COPD: insights from structure and function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Value of ²GOLD² reversibility test criteria in detecting ²reversible² chronic obstructive pulmonary disease (COPD) patients
P. Boros, M. Franczuk, S. Wesolowski (Warsaw, Poland)
Source:
Annual Congress 2004 - COPD: insights from structure and function
Session:
COPD: insights from structure and function
Session type:
Thematic Poster Session
Number:
833
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Boros, M. Franczuk, S. Wesolowski (Warsaw, Poland). Value of ²GOLD² reversibility test criteria in detecting ²reversible² chronic obstructive pulmonary disease (COPD) patients. Eur Respir J 2004; 24: Suppl. 48, 833
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Source: Guideline 1995
Year: 1995
Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 55s
Year: 2005
The usefullness of the chronic obstructive pulmonary disease assessment test
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007
Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
LATE-BREAKING ABSTRACT: The predictive value of the COPD assessment test (CAT) for acute exacerbations in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Year: 2012
The usefulness of pedometry in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012
The audit-intervention-reaudit cycle can improve diagnostic standards for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Identifying cut off scores for the chronic obstructive pulmonary disease assessment test (CAT) to predict exacerbations in COPD
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011
Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
Correlation of obstructive pulmonary disease assessement test with spirometric estimated lung age in tunisian patients of stable chronic obstructive pulmonay disease
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept